title: A New Immunotherapy Drug Creates a Watershed for the Surgical Pathologist's Role in Patient Care.
authors.forename: Philip T
authors.initials: PT
authors.lastname: Cagle
authors.affiliation: From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas.
authors.forename: Eric H
authors.initials: EH
authors.lastname: Bernicker
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D060890:B7-H1 Antigen / Q000276:immunology / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000276:immunology / Q000378:metabolism; D002289:Carcinoma, Non-Small-Cell Lung / Q000276:immunology / Q000378:metabolism / Q000628:therapy; D006801:Humans; D007150:Immunohistochemistry; D007167:Immunotherapy / Q000379:methods*; D008175:Lung Neoplasms / Q000276:immunology / Q000378:metabolism / Q000628:therapy; D000077594:Nivolumab; D010340:Pathology, Surgical / Q000379:methods*; D005791:Patient Care / Q000379:methods*; D010819:Physician's Role
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D060890:B7-H1 Antigen; D014408:Biomarkers, Tumor; C423236:CD274 protein, human; D000077594:Nivolumab